The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)


One-year outcomes in unselected patients treated with a thin-strut, platinum-chromium, paclitaxel-eluting stent: primary endpoint results from the TAXUS Element European post-approval surveillance study (TE-PROVE)

EuroIntervention 2015;10:1261-1266 published online ahead of print January 2015. DOI: 10.4244/EIJY15M01_01

1. Ferrarotto Hospital, University of Catania, Catania, Italy; 2. Pauls Stradins Clinical University Hospital, University of Latvia, Riga, Latvia; 3. Craigavon Cardiac Centre, Craigavon, United Kingdom; 4. Heart Institute, University of Pécs, Pécs, Hungar

Aims: To evaluate clinical outcomes in patients receiving the next-generation, paclitaxel-eluting, platinum-chromium TAXUS Element stent in a real-world setting.

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
One-year outcomes in 1,010 unselected patients treated with the PROMUS Element everolimus-eluting stent: the multicentre PROMUS Element European Post-Approval Surveillance Study